Thermo Fisher Scientific
81 Wyman Street
Waltham
Massachusetts
02454
United States
Tel: 781-622-1000
Fax: 781-622-1207
Website: http://www.thermofisher.com/
1479 articles with Thermo Fisher Scientific
-
Thermo Fisher Scientific Completes Acquisition of PPD, Inc.
12/8/2021
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed its acquisition of PPD, Inc. (Nasdaq: PPD), a leading global provider of clinical research services to the biopharma and biotech industry, for $17.4 billion.
-
Two years into the COVID-19 pandemic, countries are reporting the fourth wave of rising cases, driven mainly by the Delta variant, although Omicron has everybody concerned. Here’s a look.
-
New High Fidelity CRISPR Cas9 Protein Reduces Off-target Effects for More Precise Genome Editing
11/30/2021
For research applications requiring highly precise genome editing, including engineering CAR T cells and creating cellular models for disease discovery, the Invitrogen TrueCut HiFi Cas9 Protein* significantly minimizes off-target events while retaining maximum on-target editing efficiency.
-
Thermo Fisher Scientific Announces Redemption of Senior Notes - Nov 18, 2021
11/18/2021
Thermo Fisher Scientific Inc., the world leader in serving science, announced that it is giving notice of its intention to redeem the following Senior Notes, representing an aggregate total principal amount of approximately $2.2 billion, on December 3, 2021.
-
Thermo Fisher Scientific Advances Proteomics Through Select Collaborations and New Analytical Instrument Solutions
11/15/2021
Thermo Fisher Scientific Inc., the world leader in serving science, today announced innovative proteomics solutions and a series of co-marketing agreements with industry experts, advancing the throughput, comprehensiveness and quality of proteomics workflows for applications such as single-cell studies and translational research.
-
Thermo Fisher Scientific Selects Mebane, N.C. as Site for New Manufacturing Facility
11/12/2021
Thermo Fisher Scientific Inc., the world leader in serving science, announced it will build a state-of-the-art manufacturing facility in Mebane, N.C.
-
Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes - Nov 09, 2021
11/9/2021
Thermo Fisher Scientific Inc. announced that it has priced an offering of €2.8 billion aggregate principal amount of the following euro-denominated notes, which will be issued by Thermo Fisher Scientific B.V., its indirect, wholly owned finance subsidiary.
-
Thermo Fisher Scientific Declares Quarterly Dividend - Nov 04, 2021
11/4/2021
Thermo Fisher Scientific Inc., the world leader in serving science, announced that its Board of Directors has authorized a quarterly cash dividend of $0.26 per common share, payable on January 14, 2022, to shareholders of record as of December 15, 2021.
-
Thermo Fisher Scientific Showcases Investment and Innovation During CPhI Worldwide 2021
11/2/2021
At CPhI Worldwide 2021, Thermo Fisher Scientific will showcase its newest capabilities across its global pharma services network which help pharmaceutical and emerging biotech companies accelerate time to market
-
Thermo Fisher Scientific Launches New Mass Spectrometry and Chromatography Solutions at ASMS 2021
11/1/2021
ASMS 2021 – Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, is empowering scientists to drive groundbreaking discoveries with the introduction of new-generation mass spectrometry instruments, workflows and software.
-
Thermo Fisher Scientific Adds Patterned Microchip-based Technology to Liquid Chromatography Portfolio
11/1/2021
ASMS 2021 -- Thermo Fisher Scientific, the world leader in serving science, today announced its acquisition of Belgium -based PharmaFluidics, the developer of the μPAC range of micro-chip-based chromatography columns.
-
Collaboration is key to faster breakthroughs. The NIH, FDA, and 15 private organizations have announced they are joining forces for the sake of the 30 million Americans suffering from a rare disease.
-
Thermo Fisher Scientific Reports Third Quarter 2021 Results
10/27/2021
Thermo Fisher Scientific Inc., the world leader in serving science, reported its financial results for the third quarter ended October 2, 2021.
-
Thermo Fisher Scientific Publishes 2020 Corporate Social Responsibility Report
10/26/2021
Thermo Fisher Scientific Inc. today published its 2020 Corporate Social Responsibility (CSR) report, reflecting its commitment to society, stakeholders and environmental, social responsibility.
-
Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes - Oct 20, 2021
10/20/2021
Thermo Fisher Scientific Inc. announced that it has priced an offering of $5.85 billion aggregate principal amount of the following notes, each issued at par:.
-
FDA Authorizes New Saliva Sample Collection Method for High-Throughput, Automated COVID-19 Testing System
10/18/2021
Thermo Fisher Scientific, the world leader in serving science, today announced that it received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) to run COVID-19 tests from saliva samples collected with the Spectrum Solutions SpectrumDNA SDNA-1000 collection device on the Amplitude Solution.
-
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 27, 2021
10/11/2021
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter 2021 before the market opens on Wednesday, October 27, 2021, and will hold a conference call on the same day at 8:30 a.m. EDT.
-
Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes - Oct 06, 2021
10/6/2021
Thermo Fisher Scientific Inc. announced that it has priced an offering of €5.25 billion aggregate principal amount of the following euro-denominated notes, which will be issued by Thermo Fisher Scientific B.V., its indirect, wholly owned finance subsidiary.
-
New Culture Medium Supports Expansion of Natural Killer Cells for Cell and Gene Therapies
10/5/2021
Thermo Fisher Scientific today announced the launch of Gibco Cell Therapy Systems (CTS) NK-Xpander Medium, a GMP-manufactured cell culture medium that supports large-scale growth and culture of functional natural killer (NK) cells with or without the use of feeder cells.
-
Henrietta Lacks’ family accuses Thermo Fisher Scientific of profiting off the first cell line that had been shared and replicated in a lab for the development of countless medical innovations.